Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer

被引:26
|
作者
Haroun, Iman
Graham, Tracy
Poll, Aletta
Sun, Ping
Hill, Kimberley [1 ]
Weitzner, Eleanor [2 ]
Narod, Steven [3 ]
Warner, Ellen [3 ]
机构
[1] Sunnybrook Odette Canc Ctr, Dept Med, Div Med Oncol, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON M5S 1A1, Canada
关键词
BRCA1; MRI; Mastectomy; BRCA2; Surveillance; BILATERAL PROPHYLACTIC MASTECTOMY; BRCA2 MUTATION CARRIERS; TAMOXIFEN; IMPACT;
D O I
10.1016/j.breast.2011.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine the reasons that motivate women in a cohort of women under intensive surveillance for breast cancer to undergo risk-reducing mastectomy (RRM). Patients and methods: Women with a BRCA1 or BRCA2 mutation who were enrolled in an MRI-based breast screening study were eligible to participate in this survey. A self-administered questionnaire was given to women who did, and who did not terminate annual MRI-based surveillance in order to undergo RRM. The questionnaire included information on family history, risk perception and satisfaction with screening. In addition, women were asked to provide the principal reason for their choice of having preventive surgery or not, and were asked about their satisfaction with this choice. Results: 246 women without breast cancer participated in the study. Of these, 39 women (16%) elected to have RRM at some point after initiating screening. Although women who had a mother or sister with breast cancer were more likely to opt for RRM than were women with no affected first-degree relative (21% versus 10%) this did not reach statistical significance. Women who perceived their breast cancer risk to be greater than 50% were more likely to opt for RRM than were women who estimated their risk to be less than 50% (19% versus 6%). Fear of cancer was the most common reason cited for choosing to have RRM (38% of respondents) followed by having had a previous cancer, (25%), then concern over their children (16%). Conclusion: Among women with a BRCA mutation who are enrolled in an MRI-based screening program, a high perception of personal breast cancer risk and a history of breast cancer in a first-degree relative are predictors of the decision to have RRM. (C) 2011 Published by Elsevier Ltd.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [1] Contralateral risk-reducing mastectomy in sporadic breast cancer
    Murphy, John A.
    Milner, Thomas D.
    O'Donoghue, Joseph M.
    LANCET ONCOLOGY, 2013, 14 (07) : E262 - E269
  • [2] Breast cancer after bilateral risk-reducing mastectomy
    Skytte, A-B
    Cruger, D.
    Gerster, M.
    Laenkholm, A-V
    Lang, C.
    Brondum-Nielsen, K.
    Andersen, M. K.
    Sunde, L.
    Kolvraa, S.
    Gerdes, A-M
    CLINICAL GENETICS, 2011, 79 (05) : 431 - 437
  • [3] Hereditary breast cancer: screening and risk reducing surgery
    Renzulli, Matteo
    Zanotti, Simone
    Clemente, Alfredo
    Mineo, Giangaspare
    Tovoli, Francesco
    Reginelli, Alfonso
    Barile, Antonio
    Cappabianca, Salvatore
    Taffurelli, Mario
    Golfieri, Rita
    GLAND SURGERY, 2019, 8 : S142 - S149
  • [4] Surgical Outcome Measures in a Cohort of Patients at High Risk of Breast Cancer Treated by Bilateral Risk-Reducing Mastectomy and Breast Reconstruction
    Gandhi, Ashu
    Duxbury, Paula
    Clancy, Tara
    Lalloo, Fiona
    Wisely, Julie A.
    Kirwan, Cliona C.
    Foden, Philip
    Stocking, Katie
    Howell, Anthony
    Evans, D. Gareth
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 150 (03) : 496E - 505E
  • [5] Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent
    Evans, D. Gareth R.
    Lalloo, Fiona
    Ashcroft, Linda
    Shenton, Andrew
    Clancy, Tara
    Baildam, Andrew D.
    Brain, Anne
    Hopwood, Penelope
    Howell, Anthony
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) : 2318 - 2324
  • [6] Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy
    Howard, A. Fuchsia
    Bottorff, Joan L.
    Balneaves, Lynda G.
    Kim-Sing, Charmaine
    BMC WOMENS HEALTH, 2010, 10
  • [7] Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer
    AlHilli, Mariam M.
    Al-Hilli, Zahraa
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2019, 26 (02) : 253 - 265
  • [8] Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome
    Modaffari, Paola
    Ponzone, Riccardo
    Ferrari, Alberta
    Cipullo, Isabella
    Liberale, Viola
    D'Alonzo, Marta
    Maggiorotto, Furio
    Biglia, Nicoletta
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03):
  • [9] The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer
    Hartmann, Lynn C.
    Lindor, Noralane M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (05) : 454 - 468
  • [10] Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience
    Bennett, Ian
    Tourani, Saam
    Cockburn, Linda
    Reasbeck, Jane
    Grobbelaar, Neels
    Dann, Sonia
    Patrikios, Penny
    Brazier, Jane
    ANZ JOURNAL OF SURGERY, 2021, 91 (04) : 685 - 690